| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012327596 |
| P356 | DOI | 10.1186/S40303-015-0007-3 |
| P932 | PMC publication ID | 4367823 |
| P698 | PubMed publication ID | 25848535 |
| P5875 | ResearchGate publication ID | 272172317 |
| P50 | author | Iris-Tatjana Kolassa | Q21262350 |
| Maggie Schauer | Q28114638 | ||
| Stephan Kolassa | Q57912301 | ||
| Thomas W Hennessy | Q68637442 | ||
| Alexander Karabatsiakis | Q85498378 | ||
| Gilava Hamuni | Q125351001 | ||
| Sarah Wilker | Q57825678 | ||
| P2093 | author name string | Durairaj Renu | |
| Suzanne Kadereit | |||
| P2860 | cites work | N-Acetylglucosamine Inhibits T-helper 1 (Th1)/T-helper 17 (Th17) Cell Responses and Treats Experimental Autoimmune Encephalomyelitis | Q22248070 |
| A rating scale for depression | Q24564540 | ||
| Translational biomarker discovery in clinical metabolomics: an introductory tutorial | Q24598642 | ||
| Bile acids: regulation of synthesis | Q24658139 | ||
| Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids | Q28265196 | ||
| How does multiple testing correction work? | Q28267689 | ||
| Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study | Q28290553 | ||
| Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide | Q28345762 | ||
| Posttraumatic stress disorder and not depression is associated with shorter leukocyte telomere length: findings from 3,000 participants in the population-based KORA F4 study | Q28385128 | ||
| The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 | Q29547745 | ||
| Identifying differentially expressed genes using false discovery rate controlling procedures | Q29615200 | ||
| Biological studies of post-traumatic stress disorder. | Q30378702 | ||
| Effects of acute stress on cardiac endocannabinoids, lipogenesis, and inflammation in rats | Q30422093 | ||
| Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach | Q30772664 | ||
| A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study | Q33575018 | ||
| Spontaneous remission from PTSD depends on the number of traumatic event types experienced | Q58890812 | ||
| Age-related changes in bile acid synthesis and hepatic nuclear receptor expression | Q60571602 | ||
| The Nitrated Fatty Acid 10-Nitro-oleate Diminishes Severity of LPS-Induced Acute Lung Injury in Mice | Q41908262 | ||
| The association of traumatic experiences and posttraumatic stress disorder with physical morbidity in old age: a German population-based study | Q41981968 | ||
| Effects of psychotherapy on DNA strand break accumulation originating from traumatic stress | Q42463796 | ||
| Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression. | Q44217081 | ||
| Chronically administered guanosine is anticonvulsant, amnesic and anxiolytic in mice | Q44466849 | ||
| Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies | Q44751614 | ||
| Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways. | Q47978385 | ||
| Is there a role for palmitoylethanolamide in the treatment of depression? | Q48334331 | ||
| Comorbidity of PTSD in anxiety and depressive disorders: prevalence and shared risk factors | Q48334817 | ||
| Substantial reduction of naïve and regulatory T cells following traumatic stress. | Q48514426 | ||
| Plasma metabonomics as a novel diagnostic approach for major depressive disorder. | Q48760949 | ||
| Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions. | Q50955863 | ||
| Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. | Q51850457 | ||
| Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders | Q33908027 | ||
| Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice | Q34083248 | ||
| Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain | Q34107477 | ||
| The palmitoylethanolamide family: a new class of anti-inflammatory agents? | Q34123191 | ||
| N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice | Q34209630 | ||
| The development of a Clinician-Administered PTSD Scale | Q34308213 | ||
| Current status on behavioral and biological markers of PTSD: a search for clarity in a conflicting literature | Q34337921 | ||
| Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells | Q34566800 | ||
| Oral administration of inosine produces antidepressant-like effects in mice | Q34659961 | ||
| T-cell growth, cell surface organization, and the galectin-glycoprotein lattice | Q34691040 | ||
| Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. | Q34717660 | ||
| Metabolomics: a global biochemical approach to drug response and disease | Q34734298 | ||
| Metabolome in schizophrenia and other psychotic disorders: a general population-based study | Q34971495 | ||
| Protection by pantothenic acid against apoptosis and cell damage by oxygen free radicals--the role of glutathione | Q35191103 | ||
| Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. | Q35596249 | ||
| Immunomodulatory and neuroprotective effects of inosine | Q35690457 | ||
| Primary fatty acid amide metabolism: conversion of fatty acids and an ethanolamine in N18TG2 and SCP cells | Q35715609 | ||
| Metabolomic differences in heart failure patients with and without major depression | Q35757760 | ||
| Mineral and vitamin deficiencies can accelerate the mitochondrial decay of aging | Q36231327 | ||
| Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans | Q36234238 | ||
| Potential metabolite markers of schizophrenia. | Q36479055 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| Tissue-specific differences in brain phosphodiesters in late-life major depression | Q37110292 | ||
| Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress | Q37276946 | ||
| N-glycosylation profiling of plasma provides evidence for accelerated physiological aging in post-traumatic stress disorder | Q37281135 | ||
| Metabolomics: a global biochemical approach to the study of central nervous system diseases | Q37289766 | ||
| Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks | Q37409877 | ||
| Metabolomics tools for identifying biomarkers for neuropsychiatric diseases | Q37419784 | ||
| Bilirubin chemistry and metabolism; harmful and protective aspects. | Q37597193 | ||
| A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities | Q37799100 | ||
| Lipidomics of Alzheimer's disease: current status | Q37980283 | ||
| Innovation: Metabolomics: the apogee of the omics trilogy | Q37995821 | ||
| 5'-nucleotidases, nucleosides and their distribution in the brain: pathological and therapeutic implications | Q38132861 | ||
| The neuroprotective properties of palmitoylethanolamine against oxidative stress in a neuronal cell line | Q39764744 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | post-traumatic stress disorder | Q202387 |
| P304 | page(s) | 2 | |
| P577 | publication date | 2015-02-08 | |
| P1433 | published in | Journal of molecular psychiatry | Q27725329 |
| P1476 | title | Metabolite profiling in posttraumatic stress disorder | |
| P478 | volume | 3 |
| Q61456313 | Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety |
| Q38784166 | Genome to Phenome: A Systems Biology Approach to PTSD Using an Animal Model |
| Q101216972 | Insights into the role of sialylation in cancer progression and metastasis |
| Q95326051 | Looking into the genetic bases of OCD dimensions: a pilot genome-wide association study |
| Q64082145 | Metabolomic analysis of male combat veterans with post traumatic stress disorder |
| Q37200180 | Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder. |
| Q50348510 | Serum profile changes in postpartum women with a history of childhood maltreatment: a combined metabolite and lipid fingerprinting study. |
| Q41791000 | Short overview on metabolomic approach and redox changes in psychiatric disorders. |
Search more.